בטא
רדאר קליני AI
הניסוי הקליני NCT06346171 (VRIPanx-COL) עבור חרדה פרוצדורלית, כאב פרוצדורלי הוא פעיל, לא מגייס. לכל הפרטים, עיינו בתצוגת הכרטיסים של רדאר ניסויים קליניים ובכלי הגילוי של AI. אפשר גם לשאול כל דבר כאן.
מחקר אחד תואם לקריטריוני המסנן
תצוגת כרטיסים

VR Augmented Human Delivered Integrative Psychotherapy for Colonoscopy Procedural Anxiety and Pain (VRIPanx-COL) 36 וירטואלי

פעיל, לא מגייס
פרטי הניסויים הקליניים זמינים בעיקר באנגלית. רדאר קליני AI יכול לעזור! לחץ על 'הסבר את המחקר' כדי לצפות ולשוחח על מידע מהמחקר בשפה המועדפת עליך.
הניסוי הקליני NCT06346171 (VRIPanx-COL) הוא מחקר מסוג התערבותי עבור חרדה פרוצדורלית, כאב פרוצדורלי, שנמצא כעת במצב פעיל, לא מגייס. המחקר התחיל ב-1 ביוני 2024 ומתוכנן לכלול 36 משתתפים. המחקר מנוהל על ידי Grigore T. Popa University of Medicine and Pharmacy וצפוי להסתיים ב-30 בנובמבר 2025. מידע זה עודכן לאחרונה באתר ClinicalTrials.gov ב-19 במרץ 2025.
סיכום קצר
Colonoscopy is an invaluable tool for the diagnosis and management of colon diseases, especially colorectal cancer (CRC) - the third most common cancer worldwide. Its unmatched ability to detect CRC and premalignant growths makes it the gold standard; however, it is not without its challenges. Patients often experience pre-procedure anxiety and discomfort primarily related to anticipated pain, which negatively impact...הצג עוד
תיאור מפורט
The proposed VR-Facilitated Integrative Psychotherapy framework (VRIPainX-COL) leverages the immersive capabilities of VR as platform fir psychological interventions for this pilot trial is designed to assess its preliminary efficacy, acceptability, and feasibility in reducing the pre-procedural anxiety and discomfort associated with colonoscopy.

Primary Aims:

1.1 Developing a comprehensive conceptual framework for...

הצג עוד
כותרת רשמית

Evaluating a Virtual Reality Augmented Clinician-Delivered Integrative Psychotherapy Model for Non-Sedated Colonoscopy Procedural Anxiety and Pain: A Prevalidation Trial Protocol (VRIPanx-COL)

מצבים רפואיים
חרדה פרוצדורליתכאב פרוצדורלי
פרסומים
מאמרים מדעיים וניירות מחקר שפורסמו על ניסוי קליני זה:
מזהי מחקר נוספים
  • VRIPanx-COL
  • 408/06.03.2024
מספר NCT
תחילת המחקר (בפועל)
2024-06-01
עדכון אחרון שפורסם
2025-03-19
סיום המחקר (מוערך)
2025-11-30
משתתפים (מתוכנן)
36
סוג המחקר
התערבותי
שלב
לא ישים
סטטוס
פעיל, לא מגייס
מילות מפתח
colonoscopy
anxiety
pain
virtual reality
psychotherapy
מטרה ראשית
טיפול
הקצאת טיפול
אקראי
דגם מתערב
קבוצות מקבילות
עיוורון
משולש
זרועות / התערבויות
קבוצת משתתפים/זרועהתערבות/טיפול
ניסיVirtual Reality Integrative Psychotherapy
This group will undergo the same virtual reality exposure software during the colonoscopy procedure, but the psychotherapist will implement the integrative psychotherapy framework during the procedure.
Virtual Reality Integrative Psychotherapy
Music therapy: "Weightless" by Marconi Union plays continuously, bridging VR distraction and psychotherapy. Before: Patients pick a VR scene (-13 to -10 min), learn VR navigation, and practice 4-7-8 breathing with a VR flower for grounding and resilience (-10 to -9 min). They continue 4-7-8 doing Progressive Muscle Relaxation (4+7 contraction, 8 relaxation), moving from lower body to facial muscles (-8 to -5 min). V...הצג עוד
Virtual Reality Distraction
Software: Nature Treks VR nature environments. Hardware: dedicated head-mounted VR display (Oculus Rift S.) powered by a high-end computer (Laptop with at least GTX 1080 graphics card, both with processing units that lower the bottleneck chances); minimum specifications should facilitate presence while limiting cybersickness by ensuring refresh rates beyound 85 frames/second. Music therapy: "Weightless" by Marconi U...הצג עוד
מדומה להשוואהVirtual Reality Distraction
This group will be exposed to the virtual reality environment as a distraction, but although receiving support in exploring the virtual world, no psychotherapy techniques will implemented.
Virtual Reality Distraction
Software: Nature Treks VR nature environments. Hardware: dedicated head-mounted VR display (Oculus Rift S.) powered by a high-end computer (Laptop with at least GTX 1080 graphics card, both with processing units that lower the bottleneck chances); minimum specifications should facilitate presence while limiting cybersickness by ensuring refresh rates beyound 85 frames/second. Music therapy: "Weightless" by Marconi U...הצג עוד
ללא טיפולControl group
This group will undergo treatment as usual according to state-of-the-art guidelines for non-sedated colonoscopy.
לא ישים
מדדי תוצאה ראשיים
מדד תוצאהתיאור המדידהטווח זמן
Reduction in Procedure-Related Anxiety
This measure assesses the degree of reduction in anxiety related to undergoing a non-sedated colonoscopy procedure. Anxiety levels will be quantified using the Spielberger STAI-Y1 and STAI-Y2 forms, previously standardized to the Romanian population and approved by Romanian Psychological College. STAI-Y1 and Y2 are applied and interpreted by a licensed investigator, in order to ensure viability of collected data. The scale measures how respondents feel at a particular moment in time and in general, providing insight into both state and trait anxiety levels. The difference in STAI-Y1 scores from baseline (pre-intervention) to post-procedure will be analyzed to determine the effectiveness of the VR-Augmented Integrative Psychotherapy in reducing procedural anxiety compared to Sham VR Distraction and control groups.
STAY-Y1: baseline anxiety measured within 20 minutes before the procedure; post-procedural anxiety (within 20 minutes after the procedure's completion).
Pain perception
The primary measure of pain perception will be the Visual Analog Scale (VAS), a validated tool for pain assessment. This self-reported measure allows patients to rate their pain on a scale from "no pain" (0) to "worst imaginable pain" (10).
Within 20 minutes before the colonoscopy procedure (baseline) and immediately after the procedure (within 20 minutes post-procedure).
מדדי תוצאה משניים
מדד תוצאהתיאור המדידהטווח זמן
Feasibility and Acceptability of VRIP-Col Interventions
This outcome will assess the logistical feasibility and overall acceptability of the VRIP-Col interventions among patients undergoing non-sedated colonoscopy. Feasibility metrics will include the successful integration of VRIP-Col into clinical workflows, the ability to deliver the intervention to all enrolled participants without disrupting standard care procedures, and the technical reliability of VR equipment. Acceptability will be evaluated through patient and healthcare provider satisfaction surveys, focusing on the perceived usefulness, ease of use, and willingness to use or recommend the VRIP-Col interventions in the future.
Data on feasibility and acceptability will be collected within 24 hours after the colonoscopy procedure.
Qualitative Feedback on VRIP-Col Interventions
This outcome will involve the collection and analysis of qualitative feedback from patients who receive the VRIP-Col interventions and the colonoscopists who perform the procedures. Feedback will be gathered through semi-structured interviews designed to explore the perceived advantages of the VRIP-Col interventions, any obstacles encountered during their implementation, and suggestions for improvement from both the patient and provider perspectives. This qualitative analysis will provide insights into the user experience, identify potential barriers to effective implementation, and inform future refinements of the VRIP-Col approach.
Data on feasibility and acceptability will be collected within 24 hours after the colonoscopy procedure.
עוזר השתתפות
קריטריוני זכאות

גילאים מוערכים למחקר
מבוגר, גיל שלישי
גיל מינימלי למחקר
18 Years
מגדרים מוערכים למחקר
הכל
מתנדבים בריאים מתקבלים
כן
  • scheduled non-sedated colonoscopy.
  • cognitive ability to understand study aims;
  • willingness to participate and provide written consent.

  • emergency colonoscopy;

  • significant sensory-cognitive impairments;

  • potential risk of:

    1. photic seizures;
    2. photosensitivity;
    3. severe motion sickness;
    4. allergies to materials used.
  • anxiety disorders:

    1. use of psychoactive or analgesic substances;
    2. concomitant psychotherapy.
Grigore T. Popa University of Medicine and Pharmacy logoGrigore T. Popa University of Medicine and Pharmacy
הגורם האחראי למחקר
Marcel-Alexandru Gaina, חוקר ראשי, MD assist prof Marcel-Alexandru Gaina, Grigore T. Popa University of Medicine and Pharmacy
אין נתוני קשר.
1 מיקומי המחקר ב-1 מדינות

Iaşi

University of Medicine and Pharmacy Grigore T Popa, Iași, Iaşi, 700115, Romania